Grail, Inc. (NASDAQ:GRAL) CFO Sells $56,659.20 in Stock

Grail, Inc. (NASDAQ:GRALGet Free Report) CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Grail Price Performance

Shares of Grail stock opened at $29.74 on Friday. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99. The business has a 50-day moving average price of $31.81 and a 200 day moving average price of $21.29.

Grail (NASDAQ:GRALGet Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. On average, equities analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Grail

Hedge funds and other institutional investors have recently bought and sold shares of the stock. FNY Investment Advisers LLC acquired a new position in Grail in the fourth quarter valued at approximately $26,000. Lindbrook Capital LLC acquired a new position in Grail in the fourth quarter valued at approximately $28,000. State of Tennessee Department of Treasury acquired a new position in Grail in the fourth quarter valued at approximately $28,000. Sterling Capital Management LLC acquired a new position in Grail in the fourth quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in Grail in the fourth quarter valued at approximately $33,000.

Wall Street Analysts Forecast Growth

GRAL has been the topic of a number of analyst reports. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective for the company.

Read Our Latest Research Report on Grail

Grail Company Profile

(Get Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Read More

Insider Buying and Selling by Quarter for Grail (NASDAQ:GRAL)

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.